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Abstract
This study investigated the potential of pooled milk as an alternative sample type for 
foot-and-mouth disease (FMD) surveillance. Real-time RT-PCR (rRT-PCR) results of 
pooled milk samples collected weekly from five pooling facilities in Nakuru County, 
Kenya, were compared with half-month reports of household-level incidence of FMD. 
These periodic cross-sectional surveys of smallholder farmers were powered to de-
tect a threshold household-level FMD incidence of 2.5% and collected information on 
trends in milk production and sales. FMD virus (FMDV) RNA was detected in 9/219 
milk samples, and using a type-specific rRT-PCR, serotype SAT 1 was identified in 3/9 
of these positive samples, concurrent with confirmed outbreaks in the study area. 
Four milk samples were FMDV RNA-positive during the half-months when at least 
one farmer reported FMD; that is, the household-level clinical incidence was above a 
threshold of 2.5%. Additionally, some milk samples were FMDV RNA-positive when 
there were no reports of FMD by farmers. These results indicate that the pooled milk 
surveillance system can detect FMD household-level incidence at a 2.5% threshold 
when up to 26% of farmers contributed milk to pooling facilities, but perhaps even 
at lower levels of infection (i.e., below 2.5%), or when conventional disease reporting 
systems fail. Further studies are required to establish a more precise correlation with 
estimates of household-level clinical incidence, to fully evaluate the reliability of this 
approach. However, this pilot study highlights the potential use of this non-invasive, 
routinely collected, cost-effective surveillance tool, to address some of the existing 
limitations of traditional surveillance methods.
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1  | INTRODUC TION
In regions where foot-and-mouth disease (FMD) is endemic such as 
East Africa, surveillance is often dependent upon the recognition and 
reporting of clinical cases by farmers and livestock workers (Bates et 
al., 2003; Machira & Kitala, 2017; Picado et al., 2011). These passive 
surveillance activities may be supplemented by targeted case finding 
or serological surveys, but are generally infrequent due to the costs 
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and labour involved (Hadorn & Stark, 2008; Kasanga et al., 2012). 
Additionally, the capacity for undertaking outbreak investigation 
and collection of clinical specimens in resource-limited countries is 
often restricted (Kasanga et al., 2012). Furthermore, farmers may 
be deterred from informing veterinary services of suspected disease 
due to the repercussions of imposed control measures. As a con-
sequence, FMD is often under-reported, and it is often difficult to 
determine the true incidence of the disease, particularly when no-
tification relies only on passive surveillance (Knight-Jones, McLaws, 
& Rushton, 2016; Vosloo, Bastos, Sangare, Hargreaves, & Thomson, 
2002).
Serum samples can be used to measure FMD virus (FMDV)-
specific antibodies to assess the prevalence of FMD. However, 
collection of sera is invasive, and results are retrospective and less 
reliable for characterizing serotypes (or even viral lineages) circulat-
ing in a region (Hedger, Barnett, Gradwell, & Travassos Dias, 1982; 
Morris et al., 2018) and are often difficult to interpret in older ani-
mals. Typically, vesicular epithelium and fluid samples are collected 
so that detection and characterization of the causal FMDV lineage 
may be carried out to inform the epidemiological situation and con-
trol strategies (Paton, Sumption, & Charleston, 2009). However, 
these sample types may only be collected from acutely infected ani-
mals and are invasive and labour-intensive to collect. Moreover, ani-
mals with sub-clinical FMD infection are unlikely to be identified, but 
may still play an important role in disease transmission (Sutmoller & 
Casas, 2002).
Milk represents a routinely collected, non-invasive alternative 
to the traditional diagnostic sample types for FMDV. Previous 
studies have demonstrated that the mammary gland is highly sus-
ceptible to FMDV replication (Burrows, Mann, Greig, Chapman, 
& Goodridg, 1971) and that FMDV can be detected by real-time 
reverse transcription polymerase chain reaction (rRT-PCR) assays 
in milk from experimentally infected cattle, before and during 
the appearance of clinical signs, and up to 28 days post-infection 
(Armson et al., 2018; Reid et al., 2006). FMDV RNA has also been 
detected in milk samples from naturally infected cattle (Armson 
et al., 2019; Ranjan et al., 2016; Saeed et al., 2011) and buffaloes 
(Ahmed et al., 2017) in endemic settings. Furthermore, using in-
dividual milk samples collected from naturally infected cattle in 
northern Tanzania, it has been demonstrated that VP1 sequences 
could be obtained, corresponding with those generated from clin-
ical samples collected from lesions from the same animal (Armson 
et al., 2019). Concordant results were also generated between 
typing data from these milk samples and confirmed reports 
from outbreak investigations, highlighting the potential for using 
milk sampling from individual cattle as an alternative sampling 
approach.
Pooled milk has been used for the surveillance of a number 
of other diseases, including bovine viral diarrhoea (Drew, Yapp, 
& Paton, 1999; Dubovi, 2010; Hill, Reichel, & Tisdall, 2010), bru-
cellosis (Chand, Rajpurohit, Malhotra, & Poonia, 2005; Hamdy & 
Amin, 2002) and Q fever (Bauer et al., 2015; Kim, Kim, Lafferty, 
& Dubovi, 2005), allowing cost-effective disease surveillance at 
the herd level. The potential for applying this approach for the de-
tection and surveillance of FMDV has been identified in previous 
studies. For example, detection of FMDV RNA has been demon-
strated at a dilution of up to 10−7, and assuming a negligible reduc-
tion in milk yield, it could theoretically be possible to identify one 
acutely infected milking cow in a herd of up to 1,000 using pooled 
milk sampling (Armson et al., 2018). Additionally, simulation mod-
elling (Garner et al., 2016; Kompas et al., 2017; Thurmond & Perez, 
2006) suggested pooled milk could be a useful tool in enhancing 
a surveillance system for FMD and considered for regional FMD 
surveillance.
Foot-and-mouth disease has been described as a high impact 
disease among pastoralists in Kenya (Nthiwa, Alonso, Odongo, 
Kenya, & Bett, 2019; Onono, Wieland, & Rushton, 2013), and sev-
eral studies have examined the impact of FMD outbreaks on large 
scale farms (Kimani, Mwirigi, & Murithi, 2005; Lyons, Alexander, 
et al., 2015; Lyons, Stärk, et al., 2015; Mulei, Wabacha, & Mbithi, 
2001). There is a requirement for improved disease surveillance 
particularly on smallholder farms (Knight-Jones et al., 2016). In 
Kenya, smallholder dairy farmers contribute an estimated 70%–
80% of all milk sold to the dairy production chain, which, directly 
or indirectly, supplies consumers milk pooling facilities or private 
processors (Karanja, 2003; Omore, Muriuki, Kenyanjui, Owango, 
& Staal, 1999; Rademaker, Koech, Jansen, & Lee, 2016). It is pos-
sible that milk from these smallholder farmers may represent a 
useful resource for FMD surveillance. This pilot study aimed (a) 
to validate the use of pooled milk as a sample matrix for FMDV 
detection and characterization and (b) to assess the usefulness 
of pooled milk as a cost-effective, non-invasive alternative for 
FMD surveillance in Kenya whilst improving knowledge on milk 
production and selling trends. Finally, results obtained by FMDV 
rRT-PCR of milk samples from pooling facilities were tested for 
correlation with reports of clinical disease from surveys of small-
holder farmers.
2  | MATERIAL S AND METHODS
2.1 | Study area and population
The study area and population have been described previously 
(Nyaguthii et al., 2019). Briefly, the study area consisted of neighbour-
ing catchment areas of five milk pooling facilities that were recruited for 
sample collection, located within Molo, Njoro and Rongai sub-counties 
of Nakuru County, Kenya (Figure 1). This area was selected due to the 
large numbers of FMD susceptible livestock present, regular outbreaks 
of FMD and the presence of a large number of smallholder dairy farm-
ers. The milk pooling facilities were approached, and informed consent 
was provided prior to participation in the study. Catchment areas were 
constructed with the guidance of facility managers using Google Earth 
(Google Inc., USA), and as some of the catchment areas bordered or 
overlapped each other, a single spatial polygon layer was created using 
QGIS version 2.18.10 (QGIS Development Team) to define the entire 
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study area (Figure 1). Sample collection was organized so that one per-
son could visit all facilities within a few hours.
2.2 | Study design
The primary goal of the study was the detection of viral RNA by rRT-
PCR in samples collected from milk pooling facilities to be compared 
with the presence of clinical FMD above a defined threshold in the 
entire study area. In order to achieve this objective, two concurrent 
studies were performed:
1. Repeat cross-sectional surveys of smallholder dairy farmers to 
determine FMD incidence in the entire study area and improve 
knowledge on milk production and selling trends in the catch-
ment areas of the five milk pooling facilities.
2. The collection of pooled milk samples from the five milk pool-
ing facilities, at 45 weekly time points for FMDV detection by 
rRT-PCR.
2.2.1 | Cross-sectional surveys for clinical disease
A baseline survey (referred to as S1) conducted between 16 
November and 1 December 2016, with the main aim of improving 
knowledge on the FMD susceptible population has been described 
previously (Nyaguthii et al., 2019). In the present study, S1 provided 
F I G U R E  1   Map of the study area 
located in Molo, Rongai and Njoro 
sub-counties of Nakuru County, Kenya. 
Capitalized letters indicate the location 
of each milk pooling facility (A–E). 
Catchment areas for each facility are 
colour-coded. Catchment area D overlaps 
that of B. Additionally, catchment area E 
overlays C. The survey area is bordered 
with a dashed black line, and the white 
area indicates parts of the study area 
that were not within the catchment 
areas of any of the milk pooling facilities. 
Red triangles indicate the locations of 
smallholder farmers where FMD was 
reported during Survey 2. FMD, foot-
and-mouth disease [Colour figure can be 
viewed at wileyonlinelibrary.com]
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information on herd size, milk production and milk sales only, as re-
sults on FMD clinical incidence from this survey have already been 
described. The sample size for S1 was based on an expected propor-
tion of households being affected in the previous six months of 15%.
Two subsequent surveys were carried out during 23–29 March 
2017 (referred to as S2) and 20 to 26 September 2017 (referred to as 
S3). Due to a limitation on resources, S2 and S3 surveys were pow-
ered to detect a threshold household-level FMD incidence of 2.5% 
based on perfect test sensitivity and specificity, a 95% confidence 
interval and an infinite study population. Based on these parame-
ters, an online epidemiological calculator EpiTools (http://epito ols.
ausvet.com.au) (Sergeant, 2019) was used to define the number of 
households required for each survey as 120. The questionnaire used 
for S2 and S3 is available in Appendix S1.
The eligibility criteria for the study population were smallholder 
dairy farmers that owned at least one, but no more than 50 cattle, 
and had cattle located within the premises. A systematic set of spatial 
points was randomly generated within the study area polygon using 
QGIS version 2.18.10 (QGIS Development Team). During the field 
surveys, the closest smallholder dairy farm to a randomly generated 
coordinate that fitted the eligibility criteria was surveyed. This was 
considered the optimal approach in the absence of a sampling frame 
or recent census data (with the last being done in 2009). The lim-
itation of this approach is the assumption that smallholder farmers 
were evenly distributed throughout the study area. Questionnaire 
data were collected using the EpiCollect+ mobile phone application 
(Aanensen, Huntley, Feil, Al-Own, & Spratt, 2009).
To determine FMD clinical incidence for S2 and S3, farmers were 
asked whether they had observed FMD on their farm sequentially 
since the last survey. Farmers were asked to provide an indication of 
the time of the outbreak (either the first half or second half of the 
month) to allow FMD household-level clinical incidence to be esti-
mated in two week blocks of time (see statistical analysis section for 
further details). The case definition for FMD was defined as farm-
ers observing at least two of the clinical signs listed by the African 
Union—Inter African Bureau for Animal Resources (AU-IBAR, 2014) 
in at least one of their animals.
2.2.2 | Pooled milk samples
Milk samples were collected for 45 weeks (16/11/2016–20/09/2017) 
from each of the five recruited milk pooling facilities (denoted A–E), 
once per week. Milk was collected in 15-mL sterile falcon tubes di-
rectly from the 5,000-L capacity pooling tank for facilities A and B. A 
pooling tank was either not available or in use for facilities C, D and E, 
instead with milk being pooled into 50-L cans (<25 cans per facility). 
Therefore, to obtain a representative milk sample at these facilities, 
3 ml of milk was taken from each can, pooled in a jug and mixed, and a 
15 ml aliquot was taken. At each collection, the total volume of milk in 
the tank/cans and the number of farmers contributing were recorded.
Immediately upon collection, all milk samples were stored on ice 
for a maximum of 4 hr during transportation to a local −20°C storage 
facility that was equipped with a temperature monitor. Milk samples 
were stored for up to nine months (depending on sample collection 
date) and then shipped on dry ice to The Pirbright Institute (TPI) for 
subsequent laboratory analysis.
2.3 | Laboratory testing of pooled milk samples
RNA extraction and the pan-serotypic rRT-PCR assay were carried out 
in duplicate on all milk samples using an optimized method as previ-
ously described (Armson et al., 2018). Briefly, RNA was extracted from 
whole milk samples using the MagMAX™ Pathogen RNA/DNA Kit 
(Applied Biosystems®) on a MagMAX™ Express 96 Extraction Robot 
(Applied Biosystems®). rRT-PCR assays were performed using the rea-
gents, parameters and thermal cycling conditions previously reported 
(Shaw et al., 2007), with primers and probes targeting the conserved 
3D region of the FMDV genome (Callahan et al., 2002). Any milk sam-
ple with a CT value of ≤ 50 was considered positive and was subse-
quently tested by the East Africa (EA) typing rRT-PCR assays [O, A, 
Southern African Territories (SAT) 1 and SAT 2], as described previ-
ously (Bachanek-Bankowska et al., 2016). However, the fluorophores 
used on each probe were modified to A—Cy5, SAT 1—JOETM, SAT 
2—TAMRATM. This modification does not affect the sensitivity of the 
rRT-PCR assays (data not shown). Positive samples for the EA rRT-PCR 
typing assays were also defined as those with a CT value of ≤50.
FMD virus cell culture isolates were obtained from archival 
stocks held in the FAO/OIE World Reference Laboratory for foot-
and-mouth disease repository (WRLFMD), TPI, UK. Cell culture 
isolate O/SAU/1/2016 was used to prepare positive control mate-
rial for the pan-serotypic rRT-PCR assay, and O/TAN/39/2012, A/
TAN/6/2013, SAT1/KEN/72/2010 and SAT2/TAN/19/2012 were 
used for the EA-O, EA-A, EA-SAT 1 and EA-SAT 2 assays, respec-
tively, using a 10–2 dilution spiked into unpasteurized whole Jersey 
milk. Unpasteurized whole Jersey milk collected from a farm in the 
UK was used as a negative extraction control.
2.4 | Statistical analysis
Associations were tested between the incidence of clinical FMD in 
the entire study area (either above or below the 2.5% household-level 
FMD incidence threshold) and the rRT-PCR testing, both at the study 
area level and within the individual milk pooling facility catchment 
area level. The spatial coordinates of surveyed farms were assigned to 
a facility catchment area using ArcGIS version 10.6.1 (Environmental 
Systems Research Institute, Inc.) based on approximate descriptions of 
the catchment areas from facility managers (Figure 1). Descriptive and 
statistical analyses were carried out using R 3.5.3 (R Core Team, 2019) 
within RStudio IDE (RStudio Team, 2019).
Mixed effect logistic regression analysis was performed including 
the milk pooling facility variable as a random effect on the intercept. 
This was implemented to examine associations between the binary 
outcome of the rRT-PCR for weekly testing of the pooled milk samples 
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in the entire study area (i.e. FMDV RNA detected: yes/no), and the fol-
lowing explanatory variables: (1) clinical FMD incidence, (2) tank vol-
ume, (3) number of farmers contributing to the facility, (4) the average 
number of adult female cows per farm, (5) the percentage of famers 
selling to a milk pooling facility and (6) the average milk yield per cow 
per day. Variables 2 and 3 utilized weekly data collected from the pool-
ing facility at the time of milk sampling, using increments of 1,000 L for 
tank volume (variable 2) and 100 for the number of farmers contribut-
ing to the facility (variable 3). For FMD incidence (variable 1), farmers 
were asked whether they observed FMD on their farm, and when it 
occurred (in which half of the month) to create a binary variable. This 
was applied to each week of that half-month, to enable comparison 
with the weekly rRT-PCR of pooled milk (i.e. if FMD was identified on 
a farm in the second half of January, both weeks in this half-month 
period were assigned as positive for clinical FMD). Variables 4, 5 and 
6 utilized data from smallholder farmer surveys, so there were only 
three data points for weeks 3 (S1), 20 (S2) and 45 (S3). Therefore, for 
each variable, data points for the unrecorded weeks were predicted by 
linear interpolation.
A backward stepwise regression was performed to fit a final mul-
tivariate model, based on the results of a likelihood ratio tests to 
remove variables with a p value higher than 0.05.
3  | RESULTS
3.1 | Pooled milk
The average volume of milk recorded weekly in the tanks/cans 
over the entire study period was 3,019.2 (range [min–max]: 900.0–
5,400.0), 1,469.8 (200.0–4,400.0), 237.5 (50.0–578.0), 473.1 
(103.0–1,050.0) and 176.5 (90.0–270.0) L for milk pooling facilities 
A, B, C, D and E, respectively. Variabilities in milk supply were ob-
served over the study period and are shown in Figure S1. This was 
likely influenced by the number of farmers contributing to the milk 
pools, which also varied with a similar pattern. Results for individual 
milk pooling facilities are shown in Figures S2 and S3. The average 
number of farmers contributing milk to A, B, C, D and E was 915 
(range [min–max]: 450–1,500), 29 (17–50), 25 (10–60), 42 (11–57) 
and 22 (10–33), respectively. The average volume of milk sold to a 
pooling facility per farmer was 14.1 L (range [min–max]: 0.0–55.0) 
for the entire study area during the study period (Table 1).
A total of 219 pooled milk samples were collected from five fa-
cilities and tested using the pan-serotypic rRT-PCR. Milk samples 
were not collected on weeks 41–45 from facility B, due to a lack of 
milk supply, and on week 1 for facility E, as it was recruited a week 
later than the others. FMDV RNA genome was detected in 9/219 
(4.11%) milk samples, six samples from facility A and one sample from 
each of facilities B, C and D (mean CT value: 40.57, range [min–max]: 
36.15–46.74) (Figure 2). Additionally, 3/9 samples (collected at fa-
cility A) with the strongest CT values (<39) were also positive by the 
EA-SAT 1 rRT-PCR typing assay. No other serotypes were detected 
by the EA rRT-PCR typing assays in the positive milk samples. The 
detection of SAT 1 in milk was concordant with results from clinical 
lesion material collected on the 27/01/2017 and submitted to the 
WRLFMD for confirmatory diagnostics, sequencing and phyloge-
netic analyses (WRLFMD, 2017a). However, milk samples that tested 
positive during the same period were from a different facility (A) than 
the catchment area where the clinical sample was collected from (D).
3.2 | Cross-sectional surveys
Descriptive data from each survey are detailed in Table 1 for the 
entire study area and also for the catchment areas of the individual 
milk pooling facilities. The number of smallholder farmers that took 
part in S1, S2 and S3 was 220, 117 and 119, respectively. Due to 
compilation of a combined catchment area and randomization of 
the spatial coordinates generated for surveying smallholder farms 
throughout the study area, some farms were located outside the 
boundaries of the individual catchment areas of any milk pooling fa-
cilities (Figure 1). Therefore, data from 47, 15, and 18 smallholder 
farms (for S1, S2 and S3, respectively) were not included in the de-
scriptive data for individual catchment areas and only included in 
the descriptive data and regression analysis generalized to the entire 
study area (Table 1). Due to the overlap of some of the catchment 
areas, some farms were also included in the analysis for more than 
one individual catchment area.
The number of farmers in the entire study area that reported 
FMD on their farm during the 45 week study period was 4/456 
(0.88%). All of the reported cases of FMD were in S2, when 4/117 
(3.42%) farmers reported disease in their animals during either 
January or February (weeks 8–15), representing a household-level 
incidence above 2.5% during those times (Figure 2).
The average volume of milk yield daily per farm was higher for 
S1 (11.0 L, 95% CI 9.0–13.1, p = .117) and S3 (13.8 L, 95% CI 11.1–
16.5, p = .003) compared to S2 (8.9 L, 95% CI 7.0–10.7), consistent 
with the milk supply trends to facilities, and is likely related to a 
prolonged drought that took place during this time. For the entire 
study area, the largest percentage of farmers that sold to a facility 
at any time during the study period was 25.5% (S1), which was found 
to be lower during the subsequent surveys (S2 12.0%, p = .04; S3 
15.1%, p = .20). The same pattern was observed for the individual 
catchment areas, where the largest number of farmers contributing 
at any time was in catchment area B (47.5%) recorded in S1. In the 
catchment area of facility E, none of the farms surveyed sold their 
milk to a pooling facility throughout the study period.
3.3 | Correlation between FMDV RNA in milk 
samples from all pooling facilities and clinical FMD 
in the entire study area
Results from the rRT-PCR were cross-tabulated with the FMD clin-
ical incidence in the entire study area (either above or below the 
2.5% household-level FMD incidence threshold), defined as the 
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gold standard (Table 2). As each parameter was measured in dif-
ferent time periods (i.e. pooled milk was collected weekly, whereas 
the FMD incidence data collected in the surveys was recorded in 
half-month increments), half-month time periods were employed. 
Consequently, for the results of the rRT-PCR, a binary variable 
was created, where a half-month period was assigned as positive 
if there was a positive rRT-PCR result in at least one week of that 
period. Therefore, by using the half-month periods and taking the 
clinical incidence as reported by farmers in the whole study area 
as the gold standard, the pooled milk surveillance system had a 
sensitivity of 100% (95% CI 51.0%–100%) and specificity of 70.6% 
(95% CI 46.9%–86.7%) (Table 2). FMDV RNA was identified in four 
pooled milk samples collected during the period from January to 
February 2017 (weeks 8–15) when the clinical incidence at house-
hold level across the entire study area was significantly ≥2.5% 
(3.42%) (Figure 2). There were also instances where FMDV RNA 
was detected in the milk samples, but there were no correspond-
ing reports by farmers (i.e. the household-level incidence of FMD 
was not significantly above 2.5%).
Both univariable analyses and the multivariable mixed effect logis-
tic regression models were used to determine whether there was any 
association between the household-level incidence being above 2.5% 
in the entire study area and the FMD rRT-PCR results from pooled 
milk, further incorporating other predictors listed in Table 3. Based on 
the univariable analysis, there were a higher odds of observing a FMD-
positive rRT-PCR result when the clinical incidence in the whole study 
area was ≥2.5% (OR = 4.21, 95% CI = 1.02–17.30, p = .046), when the 
volume of milk supplied to the facility increases (OR = 1.78 for each 
additional 1,000 L supplied, 95% CI = 1.25–2.54, p = .002) and when 
the number of farmers contributing to the facility increases (OR = 1.27 
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A 45 4.4 (1.0–11.0) 2.7 (0.0–7.0) 8.5 (0.0–22.0) 13 (28.9) 6.8 (0.0–15.0) N/A N/A
B 40 7.9 (1.0–30.0) 3.9 (1.0–10.0) 11.6 (0.0–50.0) 19 (47.5) 13.4 (2.0–50.0) N/A N/A
C 74 4.9 (1.0–24.0) 2.2 (0.0–15.0) 9.7 (0.0–120.0) 10 (13.5) 7.9 (1.5–25.0) N/A N/A
D 35 6.3 (1.0–30.0) 3.4 (1.0–10.0) 13.4 (0.0–60.0) 9 (25.7) 18.9 (3.5–50.0) N/A N/A
E 8 3.5 (1.0–7.0) 1.9 (1.0–3.0) 6.6 (0.0–11.5) 0 (0.0) 0.0 (0.0–0.0) N/A N/A
Total study 
area
220 5.5 (1.0–42.0) 2.9 (0.0–15.0) 11.0 (0.0–140.0) 56 (25.5) 12.1 (0.0–55.0) N/A N/A
Survey 2
A 39 5.5 (1.0–46.0) 2.8 (0.0–12.0) 6.8 (0.0–46.0) 7 (18.0) 11.0 (2.0–46.0) 2 (5.1) 19 (48.7)
B 16 10.6 (1.0–40.0) 3.7 (0.0–16.0) 7.4 (0.0–35.0) 2 (12.5) 10.0 (3.0–17.0) 0 (0.0) 5 (31.3)
C 35 6.5 (2.0–44.0) 2.9 (0.0–23.0) 8.6 (0.0–50.0) 1 (2.9) 50.0 (50.0 –50.0) 2 (5.7) 7 (20.0)
D 15 9.8 (2.0–40.0) 5.1 (0.0–16.0) 11.0 (0.5–35.0) 2 (13.3) 10.0 (3.0–17.0) 0 (0.0) 1 (6.7)
E 4 3.5 (2.0–5.0) 1.5 (1.0–2.0) 4.0 (2.0–6.0) 0 (0.0) N/A 0 (0.0) 0 (0.0)
Total study 
area
117 7.3 (1.0–46.0) 3.4 (0.0–26.0) 8.9 (0.0–50.0) 14 (12.0) 14.8 (2.0–50.0) 4 (3.4) 42 (35.9)
Survey 3
A 28 5.5 (1.0–17.0) 2.9 (0.0–10.0) 11.7 (0.0–45.0) 7 (25.0) 15.7 (5.0–40.0) 0 (0.0) 0 (0.0)
B 15 7.2 (1.0–30.0) 2.7 (1.0–5.0) 12.5 (0.0–77.0) 1 (6.7) 7 (7.0 –7.0) 0 (0.0) 4 (26.7)
C 41 6.6 (2.0–44.0) 3.1 (1.0–14.0) 16.0 (3.0–48.0) 2 (4.9) 23.5 (12.0–35.0) 0 (0.0) 0 (0.0)
D 17 4.2 (1.0–16.0) 2.3 (1.0–8.0) 15.2 (0.0–95.0) 2 (11.8) 6.5 (5.0–8.0) 0 (0.0) 2 (11.8)
E 8 6.9 (3.0–14.0) 3.1 (1.0–6.0) 20.3 (4.0–32.0) 0 (0.0) N/A 0 (0.0) 0 (0.0)
Total study 
area
119 6.1 (1.0–44.0) 3.0 (0.0–16.0) 13.8 (0.0–95.0) 18 (15.1) 15.5 (4.0–40.0) 0 (0.0) 7 (5.9)
Note: N/A—not applicable as this occurred outside of the study period.
aNumber of farms surveyed. 
bFarms may sell to any milk pooling facility. 
cS2 and S3 since the previous survey. 
dS1 was a baseline survey, and results are described previously by Nyaguthii et al., 2019. 
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for each additional 100 farmers, 95% CI = 1.12–1.43, p = <.001). During 
multivariate model selection, after model simplification by removing 
non-significant terms (p > .05), only the number of farmers that con-
tribute to the facility (3) was retained as significant (OR = 1.27, 95% 
CI = 1.12–1.43, p = <.001), and there was no longer any association 
between the household-level incidence being above 2.5% in the study 
area and the FMD rRT-PCR result in the pooled milk.
Univariable and multivariable logistic regression analysis was also 
carried out using the data for each individual catchment area only (data 
not shown). The only catchment area where any significant associa-
tions were observed was for facility A, where there was a higher odds 
of observing an FMD-positive rRT-PCR result when there was an in-
crease in the number of farmers contributing to the tank (OR = 1.38 for 
each additional 100 farmers, 95% CI = 1.03–1.85, p = .031). Significant 
associations were not observed for any of the other catchment areas.
4  | DISCUSSION
Previous studies have demonstrated the potential of using milk from 
individual animals as an alternative sample type for FMDV detection 
and surveillance (Armson et al., 2019) and that it is possible to detect 
FMDV in highly diluted milk samples from individual clinical cases 
(Armson et al., 2018). This pilot study aimed to expand on this work 
and explore the use of pooled milk as a cost-effective, non-invasive 
alternative sample matrix for the surveillance of FMD by compar-
ing the household-level incidence of clinical disease to FMDV RNA 
detection by rRT-PCR from pooled milk facilities in an endemic region 
of Kenya.
According to data collected by milk pooling facilities, the num-
ber of farmers contributing milk fluctuated throughout the study 
period, with a similar pattern observed for the volume of milk sup-
plied. There was a decrease in the output of milk supplied to all fa-
cilities in or after March 2017, likely due to the effects of a drought 
that occurred in the first quarter of 2017 (World Food Programme 
Kenya, 2017). This corresponded with data collected from the 
F I G U R E  2   (a) Pan-serotypic rRT-PCR 
CT values from pooled milk samples 
collected from milk pooling facilities A, 
B, C, D and E in Nakuru County, Kenya, 
over the 45-week study period. Points 
with a grey centre represent samples that 
were also positive by the SAT 1 serotype-
specific assay (CT value displayed is for 
the pan-serotypic rRT-PCR assay). (b) 
Black squares indicate time points of 
smallholder farmer surveys 1, 2 and 3. 
Grey arrows indicate the time period for 
which FMD incidence questions were 
based for each survey. Grey shading 
indicates time points where the FMD 
incidence was ≥2.5% (as reported by 
smallholder farmers during the household 
surveys). FMD, foot-and-mouth disease
TA B L E  2   Comparison of the FMDV pan-serotypic rRT-PCR 
results of samples from all milk pooling facilities, with FMD 
incidence by farmer reports for the entire study area
 
FMD incidence ≥ 2.5%
Yes No Total
Pan-serotypic rRT-PCR of  
pooled milk samples
Positivea 4 5 9
Negative 0 12 12
Total 4 17 21
Note: Half-month periods were assigned to the results of the rRT-PCR 
of the pooled milk and deemed positive if there was a positive rRT-PCR 
result in at least one week of that period. There were a total of 21 half-
month periods for the duration of the study.
Abbreviation: FMD, foot-and-mouth disease; FMDV, FMD virus.
aA positive pan-serotypic rRT-PCR result is defined as a CT value of ≤50 
in any week of the half-month time period. 
     |  1539ARMSON et Al.
smallholder farmer surveys, demonstrating the lowest milk yield 
per farmer, and the lowest percentage of farmers supplying milk 
to a facility (12.0% for the entire study area) occurring at this time. 
The largest percentage of farmers that supplied milk to a facility 
at any time was 25.5% for the entire study area or 47.5% for an 
individual catchment area.
FMD virus RNA was detected in milk samples collected from 
pooling facilities with tanks containing up to 5,000 L. Additionally, 
typing assays confirmed the presence of SAT 1, which was concurrent 
with reports from clinical samples collected from reported outbreaks 
for confirmatory diagnostics (WRLFMD, 2017a). The average CT val-
ues obtained for the positive milk samples were high (>36), likely due 
to the dilution factor of the samples, as some were collected from 
large pools (up to 5,000 L). This corresponds with previous limit of 
detection studies (Armson et al., 2018) that predicted similar CT val-
ues (>30) for pools of this size. This study observed that an increase in 
tank volume was correlated with an increase in the number of farmers 
contributing milk, and consequently, it is probable that the likelihood 
of a FMD-infected cow that supplied milk to one of these pools is 
increased, contrary to what might be expected based on rRT-PCR test 
sensitivity. Univariable analysis supported this, suggesting a positive 
association between a FMD-positive rRT-PCR result in the pooled 
milk and the number of farmers contributing to the facility, and also 
with the volume of milk in the tank/cans at the time of sample collec-
tion. Based on these results, the likelihood of FMDV detection and 
therefore surveillance efficiency may be optimized by targeting sam-
pling on large milk pooling facilities that have milk supplied from a 
large percentage of farmers in their catchment area.
During the study period, throughout the entire study area, 
there were four reports of FMD in the smallholder farmer surveys 
in facility catchment areas A and C, all during January and February 
2017. As there was at least one FMD report in each half-month pe-
riod during these two months, the household-level incidence in the 
whole of the study area was significantly ≥2.5%. This correlated 
with FMDV detected in a milk sample collected from at least one of 
the facilities in the study area in each of these half-month periods; 
therefore, it could be assumed that the pooled milk surveillance 
system might be able to detect FMDV when the household-level 
incidence is ≥2.5%. This was supported by univariable analysis 
which indicated a positive association between an FMD-positive 
rRT-PCR result when the clinical incidence in the entire study area 
was ≥2.5%. Although the sensitivity was 100% when using clinical 
reports from farmers as the gold standard, the authors acknowl-
edge the limitations of using these half-month time steps for this 
comparative analysis. These half-month time periods for FMD re-
porting were used to simplify data recording which was based on 
farmer recall in the absence of written records.
Despite the high sensitivity, FMDV RNA was detected in five 
pooled milk samples that were collected when there were no clin-
ical FMD reports, and the possibility that these results are due to 
laboratory contamination cannot be excluded. However, measures 
were implemented to minimize the likelihood of this occurring, and 
the laboratory methodology used in this study has been shown to be 
highly specific (data not shown). Additionally, as there were negative 
controls, and a high number of ‘negative’ samples where no amplifi-
cation was observed on the rRT-PCR assay, this further supports the 
theory that these positive milk samples are unlikely due to labora-
tory contamination or non-specific amplification and that there may 
be further alternative explanations.
It is possible that the study was underpowered, due to limited 
resources available, and therefore, the clinical disease threshold of 
2.5% was too high to robustly assess specificity. In future studies, a 
more precise evaluation of sensitivity and specificity of the pooled 
milk detection system may be achieved if surveys are powered to 
detect a lower threshold FMD incidence. Farmers in this region of 
Kenya had good knowledge of FMD (Nyaguthii et al., 2019), which 
was validated by the descriptions of clinical signs by farmers corre-
sponding with the case definition. However, it is possible that mild 
clinical signs or sub-clinical infection could reduce the likelihood of 
farmer reporting and provide explanation for instances where there 
were positive milk samples but no farmer reports of disease. Further 
investigation is required to determine the incidence of sub-clinically 
infected animals in this region, for example by using serological 
surveys, and whether virus particles may be present in the milk of 
sub-clinically infected animals (Sutmoller & Casas, 2002). Further in-
vestigation is also required into the impact of vaccination on FMDV 
excretion in milk. During the study period, vaccination was carried 
out in response to an outbreak. Whether vaccination in these herds 
Variable Type of variable Odds ratio (95% CI) p Value
1. FMD incidence Categorical 4.21 (1.02–17.31) .046
2. Tank volume (per 1,000 L) Continuous 1.78 (1.25–2.54) .002
3. Number of farmers 
contributing to the facility (per 
100 farmers)
Continuous 1.27 (1.12–1.43) <.001
4. Average number of adult 
female cows per farm
Continuous 0.99 (0.26–3.78) .990
5. Percentage of farmers selling 
to a milk pooling facility
Continuous 1.04 (0.96–1.11) .358
6. Average milk yield per cow Continuous 0.48 (0.15–1.49) .203
Abbreviation: FMD, foot-and-mouth disease.
TA B L E  3   Univariate mixed effect 
logistic regression analysis for association 
with a positive FMD rRT-PCR result for 
the total study area
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may increase the likelihood of sub-clinical infection is unknown, 
although there have been reports of sub-clinical infection in vac-
cinated animals (Donaldson & Kitching, 1989; Hutber, Kitching, & 
Conway, 1999; Lyons et al., 2017) and virus excretion in the milk of 
apparently healthy vaccinated animals (Ahmed et al., 2017).
Of the milk samples positive by the pan-serotypic rRT-PCR assay, 
3 were identified as SAT 1 but no amplification was observed in any 
of the EA typing rRT-PCR assays for the other samples. Outbreaks 
due to the circulation of type O outside of the study area were re-
ported in August 2017 (WRLFMD, 2017b). It is possible that these 
samples were at the limit of detection for the EA-O rRT-PCR typing 
assay, as this assay has been shown to have a slightly reduced ana-
lytical sensitivity compared with the pan-serotypic rRT-PCR assay 
(Bachanek-Bankowska et al., 2016). It is also possible that another 
lineage of FMDV was also circulating in the region that cannot be 
detected by the EA typing assays used.
Several methodological issues arose during this study that may 
have affected the results of FMD clinical incidence and therefore 
the sensitivity and specificity estimations of the pooled milk sur-
veillance system. The original aim of the study was to undertake 
smallholder farmer surveys within the catchment areas of the milk 
pooling facilities. Catchment areas were approximated by facility 
managers, and as some of the catchment areas either bordered or 
overlapped each other, a single spatial polygon was created to de-
fine the whole study area. It is unclear how precise these catch-
ment areas were, as in some cases farmers from one catchment 
area reported supplying milk to a neighbouring catchment area. 
This may explain cases where there was positive report of FMD by 
a farmer in one catchment area, but there were no rRT-PCR posi-
tive milk samples from the area's pooling facility in that time period 
(e.g. catchment area C). Additionally, some of the surveyed farms 
were located in more than one catchment area (due to overlap of 
the catchment areas), or none of the catchment areas (due to being 
between catchment areas), which may have led to bias in the de-
scriptive data and analysis. Due to the absence of an available sam-
pling frame, it was assumed that smallholder farmers were evenly 
distributed throughout the whole study area. This was a reason-
able assumption based on the knowledge of the authors and animal 
health assistants in the area, although any disparity may have led 
to an inaccurate estimation of household-level incidence. In addi-
tion, the intention of the study was to recruit milk pooling facilities 
that stored milk in bulk tanks for the collection of milk samples. 
However, three of the facilities either did not have, or were not 
using their bulk tanks, and instead pooled milk in 50-L cans. The 
reasons for not using an existing bulk-tank included a low milk sup-
ply and not being fully functional. Consequently, a small volume 
of milk from each can was pooled and mixed in order to obtain a 
sample representative of the whole milk pool from this facility. The 
authors recognize the limitations in this approach, and further sam-
pling methodologies for facilities using cans should be explored.
This pilot study describes the rRT-PCR testing of milk samples 
from milk pooling facilities as a simple surveillance approach for FMD 
in this endemic region of Kenya. Based on data from the entire study 
area, by utilizing the weekly collection of milk samples, it was possible 
to detect and type FMDV RNA by rRT-PCR from milk pools of up to 
5,000 L, when the FMD clinical incidence was ≥2.5%, and when fewer 
than 25% of farmers were selling their milk to these pooling facilities. 
Based on the results obtained in this study, further investigation is 
required to obtain a more precise correlation of household-level inci-
dence with pooled milk sample results, to fully assess the usefulness 
of this novel surveillance approach. With more resources available, 
this could be achieved by combining clinical surveys of FMD infection 
at the individual animal level and serological surveys with sufficient 
statistical powers to detect a low incidence of infection or disease. 
Additionally, the collection of pooled milk samples should be focussed 
on larger facilities, which have a large number of contributing farm-
ers from the surrounding area. Furthermore, pooling systems higher 
up the dairy production chain should also be explored as a target for 
FMD surveillance, although the possible reduced ability in detecting 
FMDV RNA from milk samples after pasteurization. Follow-on studies 
should also investigate the establishment of sentinel systems in the 
epidemiological surveillance of FMD, and how geographical limits that 
may encompass different farming practices may affect this solution.
In conclusion, this pilot study highlights that this novel, simple 
surveillance approach has the potential to address some of the 
well-recognized limitations of more traditional surveillance methods 
in resource-limited countries and to improve the capacity for sur-
veillance which could contribute to informing and evaluating disease 
control policies in these endemic regions.
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